Home » Newsletters » BioWorld

BioWorld

April 1, 1993

View Archived Issues

NIH COMPARES HIV VACCINES IN CHILDREN

XOMA'S CHAIRMAN LEAVES FOR PRIZM

LTI COUNTERSUES VESTAR OVER PATENT

IMMUNEX AMENDS PRODUCT LICENSE

FDA PANEL RECOMMENDS APPROVAL OF BST

SOD ENZYME SUPPRESSES CANCER GROWTH

USDA BIOTECH REGS PUBLISHED

ARGUS STARTS TRIAL FOR LEUKEMIA TREATMENT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...